Phil has 15 years experience in the biotech/pharma industry, in R&D, IP management, licensing & partnering and corporate development. Prior to joining CRT, Phil headed up licensing at BioFocus Discovery Ltd, an AIM-listed integrated early stage drug discovery company. Prior to BioFocus, Phil was CSO and more recently CEO of ProBio Inc, a US specialty IP commercialisation company involved in international licensing and partnering in the Life Sciences sectors, prior to its sale to Pharming Group NV. He has also been a consultant to industry advising clients on R&D and commercialisation strategies, and has worked across several continents, including North America, Europe, New Zealand and Australia. Phil holds an MBA, and a PhD in cellular and molecular biology and is a Director of Hybrid Systems Ltd.